Paragon Wealth Strategies »

Vertex Pharmaceuticals Incorporated shares owned by Paragon Wealth Strategies

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Paragon Wealth Strategies from 13F filings

Historical chart of Paragon Wealth Strategies investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Paragon Wealth Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Paragon Wealth Strategies

Quarter filed Position value Share count Share price at filing
2023-12-31 $534k 1.3k 406.89
2023-09-30 $457k 1.3k 347.74
2023-06-30 $286k 813 351.91
2023-03-31 $256k 813 315.07
2022-12-31 $192k 663 288.78
2022-09-30 $120k 413 290.56

More positions owned by Paragon Wealth Strategies

Vanguard S&p 500 Etf Etf (VOO)
Dimensional International Value Etf Etf (DFIV)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Ishares Russell 1000 Growth Etf Etf (IWF)
Powershares Qqq Tr Etf (QQQ)
Pacer Us Small Cap Cash Cows 100 Etf Etf (CALF)
Dimensional Us High Profitability Etf Etf (DUHP)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Neos Etf Trust Etf (CSHI)
Ishares Investment Grade Bond Factor Etf Etf (IGEB)
Ishares 20 Yr Treasury Etf Etf (TLT)
Apple Stock (AAPL)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Microsoft Stock (MSFT)
Berkshire Hathaway Inc Del Cl A Stock (BRK.A)

View all positions for Paragon Wealth Strategies

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
T. Rowe Price Associates
Geode Capital Management
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
Legal & General Group

View all funds holding Vertex Pharmaceuticals Incorporated